- Q2 2024 Eris Lifesciences Ltd Earnings Call TranscriptNov 08, 2023₹897.8 (+3.30%)Earnings
- Q1 2024 Eris Lifesciences Ltd Earnings Call TranscriptAug 07, 2023₹828.2 (+3.45%)Earnings
- Q4 2023 Eris Lifesciences Ltd Earnings Call TranscriptMay 17, 2023₹636.65 (+1.06%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Eris Lifesciences Ltd Earnings Call TranscriptJan 17, 2023₹651.8 (+0.50%)Earnings
- Q2 2023 Eris Lifesciences Ltd Earnings Call TranscriptOct 20, 2022₹707.85 (-2.92%)Earnings
- Q1 2023 Eris Lifesciences Ltd Earnings Call TranscriptAug 05, 2022₹694.75 (-0.81%)Earnings
- Q4 2022 Eris Lifesciences Ltd Earnings Call TranscriptMay 04, 2022₹663.35 (-1.86%)Earnings
- Q3 2022 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2022₹696.2 (-2.04%)Earnings
- Eris Lifesciences Ltd To Discuss Joint Venture with Mj Biopharm Pvt Ltd Call TranscriptDec 04, 2021
- Q2 2022 Eris Lifesciences Ltd Earnings Call TranscriptOct 29, 2021₹821 (+4.73%)Earnings
- Q1 2022 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2021₹771.15 (+3.91%)Earnings
- Q4 2021 Eris Lifesciences Ltd Earnings Call TranscriptMay 13, 2021₹653.85Earnings
- Q3 2021 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2021₹623.1 (+2.03%)Earnings
- Q2 2021 Eris Lifesciences Ltd Earnings Call TranscriptNov 03, 2020₹518.1 (+1.46%)Earnings
- Q1 2021 Eris Lifesciences Ltd Earnings Call TranscriptAug 04, 2020₹510.95 (-5.48%)Earnings
- Q4 2020 Eris Lifesciences Ltd Earnings Call TranscriptJun 02, 2020₹519.2 (-1.59%)Earnings
- Q3 2020 Eris Lifesciences Ltd Earnings Call TranscriptFeb 14, 2020₹465.5 (-11.33%)Earnings
- Q2 2020 Eris Lifesciences Ltd Earnings Call TranscriptNov 07, 2019₹425.55 (+4.61%)Earnings
- Q1 2020 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2019₹394.8 (-1.62%)Earnings
- Q4 2019 Eris Lifesciences Ltd Earnings Call TranscriptMay 21, 2019₹605.6 (-1.37%)Earnings
Q3 2021 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q3 FY 2021 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Good afternoon, everyone. Am I audible?
Yes, sir. You are clear and audible.
Great. I'm Krishnakumar, and a hearty welcome to our Q3 conference call. I'm happy to share this quarter's highlights with you.
To begin with, I'm happy to report that the domestic pharmaceutical industry, which we refer to as the IPM, it has returned to more normalcy in terms of operations, and the market has registered a growth of 6.4% in Q3. This is in comparison to 1.1% growth last quarter and a negative 5.2% growth in Q1.
The growth for the month of December has been 8.5%. This growth has been led by chronic and subchronic therapies,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)